The role of 18 kDa mitochondrial translocator protein (TSPO) in programmed cell death, and effects of steroids on TSPO expression

Current Molecular Medicine

Volumn 12, Issue 4, 2012, Pages 398-412

  Veenman, L ^a   Gavish, M ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Adenine nucleotide transporter (ANT); Bcl2; Brain trauma; Cholesterol; Creatine kinase; Cyclophylin D; Hexokinase; Voltage dependent anion channel (VDAC)

Indexed keywords

ADENOSINE TRIPHOSPHATE; BENZODIAZEPINE RECEPTOR; DIAZEPAM BINDING INHIBITOR; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; MITOCHONDRIAL PROTEIN; PHOSPHOLIPASE A2; PROTOPORPHYRIN; REACTIVE OXYGEN METABOLITE; STEROID; TRANSLOCATOR PROTEIN; TRIACONTATETRANEUROPEPTIDE; UNCLASSIFIED DRUG;

APOPTOSIS; BRAIN; BRAIN INJURY; EMBRYO DEVELOPMENT; GENITAL SYSTEM; HUMAN; INJURY; KIDNEY; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; STEROIDOGENESIS; TISSUE DISTRIBUTION;

ANIMALS; APOPTOSIS; BENZODIAZEPINONES; BRAIN; GENE EXPRESSION; HUMANS; ISOQUINOLINES; LIGANDS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIAL ADP, ATP TRANSLOCASES; PROTEIN BINDING; REACTIVE OXYGEN SPECIES; RECEPTORS, GABA; STEROIDS; VOLTAGE-DEPENDENT ANION CHANNELS;

EID: 84860279460     PISSN: 15665240     EISSN: 18755666     Source Type: Journal    
DOI: None     Document Type: Review

References (184)

1. Braestrup C, Squires RF. Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding. Proc Natl Acad Sci USA 1977; 74: 3805-9.
2. Verma A, Snyder SH. Peripheral type benzodiazepine receptors. Annu Rev Pharmacol Toxicol 1989; 29: 307-22.
3. Cosenza-Nashat M, Zhao ML, Suh HS, et al. Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain. Neuropathol Appl Neurobiol 2009; 35: 306-28.
4. Gavish M, Bachman I, Shoukrun R, et al. Enigma of the peripheral benzodiazepine receptor. Pharmacol Rev 1999; 51: 629-50.
5. Papadopoulos V, Baraldi M, Guilarte TR, et al. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 2006; 27: 402-9.
6. Veenman L, Papadopoulos V, Gavish M. Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response. Curr Pharm Des 2007; 13: 2385-405.
7. Anholt RR, Pedersen PL, De Souza EB, Snyder SH. The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. J Biol Chem 1986; 261: 576-83.
8. Krueger KE, Papadopoulos V. Peripheral-type benzodiazepine receptors mediate translocation of cholesterol from outer to inner mitochondrial membranes in adrenocortical cells. J Biol Chem 1990; 265: 15015-22.
9. Bisland SK, Goebel EA, Hassanali NS, Johnson C, Wilson BC. Increased expression of mitochondrial benzodiazepine receptors following low-level light treatment facilitates enhanced protoporphyrin IX production in glioma-derived cells in vitro. Lasers Surg Med 2007; 39: 678-84.
10. Bernassau JM, Reversat JL, Ferrara P, Caput D, Lefur G. A 3D model of the peripheral benzodiazepine receptor and its implication in intra mitochondrial cholesterol transport. J Mol Graph 1993; 11: 236-44, 235.
11. McEnery MW, Snowman AM, Trifiletti RR, Snyder SH. Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc Natl Acad Sci USA 1992; 89: 3170-4.
12. Olson JM, Ciliax BJ, Mancini WR, Young AB. Presence of peripheral-type benzodiazepine binding sites on human erythrocyte membranes. Eur J Pharmacol 1988; 152: 47-53.
13. O'Beirne GB, Woods MJ, Williams DC. Two subcellular locations for peripheral-type benzodiazepine acceptors in rat liver. Eur J Biochem 1990; 188: 131-8.
14. Hardwick M, Fertikh D, Culty M, Li H, Vidic B, Papadopoulos V. Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol. Cancer Res 1999; 59: 831-42.
15. Brown RC, Degenhardt B, Kotoula M, Papadopoulous V. Location-dependent role of the human glioma cell peripheraltype benzodiazepine receptor in proliferation and steroid biosynthesis. Cancer Lett 2000; 156: 125-32.
16. Corsi L, Geminiani E, Avallone R, Baraldi M. Nuclear location-dependent role of peripheral benzodiazepine receptor (PBR) in hepatic tumoral cell lines proliferation. Life Sci 2005; 76: 2523-33.
17. Otera H, Taira Y, Horie C, et al. A novel insertion pathway of mitochondrial outer membrane proteins with multiple transmembrane segments. J Cell Biol 2007; 179: 1355-63.
18. Veenman L, Gavish M. The peripheral-type benzodiazepine receptor and the cardiovascular system. Implications for drug development. Pharmacol Ther 2006; 110: 503-24.
19. Veenman L, Shandalov Y, Gavish M. VDAC activation by the 18 kDa translocator protein (TSPO), implications for apoptosis. J Bioenerg Biomembr 2008; 40: 199-205.
20. Papadopoulos V, Lecanu L. Translocator protein (18 kDa) TSPO: an emerging therapeutic target in neurotrauma. Exp Neurol 2009; 219: 53-7.
21. Guidotti A, Forchetti CM, Corda MG, Konkel D, Bennett CD, Costa E. Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc Natl Acad Sci USA 1983; 80: 3531-5.
22. Doble A, Burgevin MC, Ménager J, et al. Partial purification and pharmacology of peripheral-type benzodiazepine receptors. J Recept Res 1987; 7: 55-70.
23. Verma A, Nye JS, Snyder SH. Porphyrins are endogenous ligands for the mitochondrial (peripheral-type) benzodiazepine receptor. Proc Natl Acad Sci USA 1987; 84: 2256-60.
24. Braestrup C, Albrechtsen R, Squires RF. High densities of benzodiazepine receptors in human cortical areas. Nature 1977; 269: 702-4.
25. Le Fur G, Perrier ML, Vaucher N, et al. Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide: I. In vitro studies. Life Sci 1983: 32: 1839-47.
26. Le Fur G, Guilloux F, Rufat P, et al. Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-(1-methylpropyl)-3 isoquinolinecarboxamide: II. In vivo studies. Life Sci 1983; 32: 1849-56.
27. Le Fur G, Vaucher N, Perrier ML, et al. Differentiation between two ligands for peripheral benzodiazepine binding sites, [3H]RO5-4864 and [3H]PK 11195, by thermodynamic studies. Life Sci 1983; 33: 449-57.
28. James ML, Selleri S, Kassiou M. Development of ligands for the peripheral benzodiazepine receptor. Curr Med Chem 2006; 13: 1991-2001.
29. Veenman L, Weizman A, Weisinger G, Gavish M. Expression and Functions of the 18 kDa Mitochondrial Translocator Protein (TSPO) in Health and Disease. In: Targeted Drug Delivery in Cancer Therapeutics. Editor: Michael A. Firer: Transworld Research Network: Kerala, India, 2010a: pp 49-84.
30. Galiegue S, Tinel N, Casellas P. The peripheral benzodiazepine receptor: a promising therapeutic drug target. Curr Med Chem 2003; 10: 1563-72.
31. Decaudin D. Peripheral benzodiazepine receptor and its clinical targeting. Anticancer Drugs 2004; 15: 737-45.
32. Zoratti M, Szabò I. The mitochondrial permeability transition. Biochim Biophys Acta 1995; 1241: 139-76.
33. Shimizu S, Konishi A, Kodama T, Tsujimoto Y. BH4 domain of antiapoptotic Bcl-2 family members closes voltagedependent anion channel and inhibits apoptotic mitochondrial changes and cell death. Proc Natl Acad Sci USA 2000; 97: 3100-5. Erratum in: Proc Natl Acad Sci USA 2000; 97: 9347.
34. Szabó I, De Pinto V, Zoratti M. The mitochondrial permeability transition pore may comprise VDAC molecules. II. The electrophysiological properties of VDAC are compatible with those of the mitochondrial megachannel. FEBS Lett 1993; 330: 206-10.
35. Vieira HL, Haouzi D, El Hamel C, et al. Permeabilization of the mitochondrial inner membrane during apoptosis: impact of the adenine nucleotide translocator. Cell Death Differ 2000; 7: 1146-54.
36. Jonas EA. Molecular participants in mitochondrial cell death channel formation during neuronal ischemia. Exp Neurol 2009; 218: 203-12.
37. Ryu SY, Peixoto PM, Teijido O, Dejean LM, Kinnally KW. Role of mitochondrial ion channels in cell death. Biofactors 2010; 36: 255-63.
38. Siesjö BK, Elmér E, Janelidze S, et al. Role and mechanisms of secondary mitochondrial failure. Acta Neurochir Suppl 1999; 73: 7-13.
39. Blom WM, de Bont HJ, Nagelkerke JF. Regional loss of the mitochondrial membrane potential in the hepatocyte is rapidly followed by externalization of phosphatidylserines at that specific site during apoptosis. J Biol Chem 2003; 278: 12467-74.
40. Rogalska A, Koceva-Chyła A, Jóźwiak Z. Aclarubicin-induced ROS generation and collapse of mitochondrial membrane potential in human cancer cell lines. Chem Biol Interact 2008; 176: 58-70.
41. Kroemer G, Dallaporta B, Resche-Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 1998; 60: 619-42.
42. Papadopoulos V, Boujrad N, Ikonomovic MD, Ferrara P, Vidic B. Topography of the Leydig cell mitochondrial peripheral-type benzodiazepine receptor. Mol Cell Endocrinol 1994; 104: R5-9.
43. Ostuni MA, Péranzi G, Ducroc RA, et al. Distribution, pharmacological characterization and function of the 18 kDa translocator protein in rat small intestine. Biol Cell 2009; 101: 573-86.
44. Veenman L, Levin E, Weisinger G, et al. Peripheral-type benzodiazepine receptor density and in vitro tumorigenicity of glioma cell lines. Biochem Pharmacol 2004; 68: 689-98.
45. Veenman L, Alten J, Linnemannstöns K, et al. Potential involvement of F0F1-ATP(synth)ase and reactive oxygen species in apoptosis induction by the antineoplastic agent erucylphosphohomocholine in glioblastoma cell lines: a mechanism for induction of apoptosis via the 18 kDa mitochondrial translocator protein. Apoptosis 2010b; 15: 753-68.
46. Levin E, Premkumar A, Veenman L, et al. The peripheraltype benzodiazepine receptor and tumorigenicity: isoquinoline binding protein (IBP) antisense knockdown in the C6 glioma cell line. Biochemistry 2005; 44: 9924-35.
47. Chelli B, Salvetti A, Da Pozzo E, et al. PK 11195 differentially affects cell survival in human wild-type and 18 kDa translocator protein-silenced ADF astrocytoma cells. J Cell Biochem 2008; 105: 712-23.
48. Kugler W, Veenman L, Shandalov Y, et al. Ligands of the mitochondrial 18 kDa translocator protein attenuate apoptosis of human glioblastoma cells exposed to erucylphosphohomocholine. Cell Oncol 2008; 30: 435-50.
49. Mills C, Makwana M, Wallace A, et al. Ro5-4864 promotes neonatal motor neuron survival and nerve regeneration in adult rats. Eur J Neurosci 2008; 27: 937-46.
50. Shoukrun R, Veenman L, Shandalov Y, et al. The 18-kDa translocator protein, formerly known as the peripheral-type benzodiazepine receptor, confers proapoptotic and antineoplastic effects in a human colorectal cancer cell line. Pharmacogenet Genomics 2008; 18: 977-88.
51. Fafalios A, Akhavan A, Parwani AV, Bies RR, McHugh KJ, Pflug BR. Translocator protein blockade reduces prostate tumor growth. Clin Cancer Res 2009; 15: 6177-84.
52. Zeno S, Zaaroor M, Leschiner S, Veenman L, Gavish M. CoCl(2) induces apoptosis via the 18 kDa translocator protein in U118MG human glioblastoma cells. Biochemistry 2009; 48: 4652-61.
53. Schaller S, Paradis S, Ngoh GA, et al. TRO40303, a new cardioprotective compound, inhibits mitochondrial permeability transition. J Pharmacol Exp Ther 2010; 333: 696-706.
54. Margiotta N, Denora N, Ostuni R, et al. Platinum(II) complexes with bioactive carrier ligands having high affinity for the translocator protein. J Med Chem 2010; 53: 5144-54.
55. Bertomeu T, Zvereff V, Ibrahim A, et al. TLN-4601 peripheral benzodiazepine receptor (PBR/TSPO) binding properties do not mediate apoptosis but confer tumor-specific accumulation. Biochem Pharmacol 2010; 80: 1572-9.
56. Verrier F, Mignotte B, Jan G, Brenner C. Study of PTPC composition during apoptosis for identification of viral protein target. Ann N Y Acad Sci 2003; 1010: 126-42.
57. Shore GC. Apoptosis: it's BAK to VDAC. EMBO Rep 2009; 10: 1311-3.
58. Shoshan-Barmatz V, De Pinto V, Zweckstetter M, Raviv Z, Keinan N, Arbel N. VDAC, a multi-functional mitochondrial protein regulating cell life and death. Mol Aspects Med 2010; 31: 227-85.
59. Kinnally KW, Peixoto PM, Ryu SY, Dejean LM. Is mPTP the gatekeeper for necrosis, apoptosis, or both? Biochim Biophys Acta 2011; 1813: 616-22
60. Lindsay J, Esposti MD, Gilmore AP. Bcl-2 proteins and mitochondria--specificity in membrane targeting for death. Biochim Biophys Acta 2011; 1813: 532-9.
61. Westphal D, Dewson G, Czabotar PE, Kluck RM. Molecular biology of Bax and Bak activation and action. Biochim Biophys Acta 2011; 1813: 521-31.
62. Soustiel JF, Zaaroor M, Vlodavsky E, Veenman L, Weizman A, Gavish M. Neuroprotective effect of Ro5-4864 following brain injury. Exp Neurol 2008a; 214: 201-8.
63. Soustiel JF, Palzur E, Vlodavsky E, Veenman L, Gavish M. The effect of oxygenation level on cerebral post-traumatic apoptotsis is modulated by the 18-kDa translocator protein (also known as peripheral-type benzodiazepine receptor) in a rat model of cortical contusion. Neuropathol Appl Neurobiol 2008b; 34: 412-23.
64. Pedersen PL. Voltage dependent anion channels (VDACs): a brief introduction with a focus on the outer mitochondrial compartment's roles together with hexokinase-2 in the Warburg effect in cancer. J Bioenerg Biomembr 2008; 40: 123-6.
65. Ferrarese C, Pierpaoli C, Linfante I, et al. Peripheral benzodiazepine receptors and glucose metabolism in human gliomas. J Neurooncol 1994; 22: 15-22.
66. Rasola A, Sciacovelli M, Pantic B, Bernardi P. Signal transduction to the permeability transition pore. FEBS Lett 2010; 584: 1989-96.
67. Schlattner U, Tokarska-Schlattner M, Ramirez S, et al. Mitochondrial kinases and their molecular interaction with cardiolipin. Biochim Biophys Acta 2009; 1788: 2032-47.
68. Lucken-Ardjomande HS. Cholesterol, cardiolipin, and mitochondria permeabilisation. Anticancer Agents Med Chem. 2011 (Epub ahead of print).
69. Giorgio V, Bisetto E, Soriano ME, et al. Cyclophilin D modulates mitochondrial F0F1-ATP synthase by interacting with the lateral stalk of the complex. J Biol Chem 2009; 284: 33982-8.
70. Galiègue S, Jbilo O, Combes T, et al. Cloning and characterization of PRAX-1. A new protein that specifically interacts with the peripheral benzodiazepine receptor. J Biol Chem 1999; 274: 2938-52.
71. West LA, Horvat RD, Roess DA, Barisas BG, Juengel JL, Niswender GD. Steroidogenic acute regulatory protein and peripheral-type benzodiazepine receptor associate at the mitochondrial membrane. Endocrinology 2001; 142: 502-5.
72. Li H, Degenhardt B, Tobin D, Yao ZX, Tasken K, Papadopoulos V. Identification, localization, and function in steroidogenesis of PAP7: a peripheral-type benzodiazepine receptor-and PKA (RIalpha)-associated protein. Mol Endocrinol 2001; 15: 2211-28.
73. Liu J, Li H, Papadopoulos V. PAP7, a PBR/PKA-RIalphaassociated protein: a new element in the relay of the hormonal induction of steroidogenesis. J Steroid Biochem Mol Biol 2003; 85: 275-83.
74. Blahos J 2nd, Whalin ME, Krueger KE. Identification and purification of a 10-kilodalton protein associated with mitochondrial benzodiazepine receptors. J Biol Chem 1995; 270: 20285-91.
75. Chardenot P, Roubert C, Galiègue S, et al. Expression profile and up-regulation of PRAX-1 mRNA by antidepressant treatment in the rat brain. Mol Pharmacol 2002; 62: 1314-20.
76. Mukhin AG, Papadopoulos V, Costa E, Krueger KE. Mitochondrial benzodiazepine receptors regulate steroid biosynthesis. Proc Natl Acad Sci USA 1989; 86: 9813-6.
77. Papadopoulos V, Berkovich A, Krueger KE. The role of diazepam binding inhibitor and its processing products at mitochondrial benzodiazepine receptors: regulation of steroid biosynthesis. Neuropharmacology 1991; 30: 1417-23.
78. Mirzatoni A, Spence RD, Naranjo KC, Saldanha CJ, Schlinger BA. Injury-induced regulation of steroidogenic gene expression in the cerebellum. J Neurotrauma 2010; 27: 1875-82.
79. Rone MB, Fan J, Papadopoulos V. Cholesterol transport in steroid biosynthesis: role of protein-protein interactions and implications in disease states. Biochim Biophys Acta 2009; 1791: 646-58.
80. Whalin ME, Boujrad N, Papadopoulos V, Krueger KE. Studies on the phosphorylation of the 18 kDa mitochondrial benzodiazepine receptor protein. J Recept Res 1994; 14: 217-28.
81. Tanimoto Y, Onishi Y, Sato Y, Kizaki H. Benzodiazepine receptor agonists modulate thymocyte apoptosis through reduction of the mitochondrial transmembrane potential. Jpn J Pharmacol 1999; 79: 177-83.
82. Krestinina OV, Grachev DE, Odinokova IV, Reiser G, Evtodienko YV, Azarashvili TS. Effect of peripheral benzodiazepine receptor (PBR/TSPO) ligands on opening of Ca2+-induced pore and phosphorylation of 3.5-kDa polypeptide in rat brain mitochondria. Biochemistry (Mosc) 2009; 74: 421-9.
83. Chelli B, Lena A, Vanacore R, et al. Peripheral benzodiazepine receptor ligands: mitochondrial transmembrane potential depolarization and apoptosis induction in rat C6 glioma cells. Biochem Pharmacol 2004; 68: 125-34.
84. Kupczyk-Subotkowska L, Siahaan TJ, Basile AS, et al. Modulation of melphalan resistance in glioma cells with a peripheral benzodiazepine receptor ligand-melphalan conjugate. J Med Chem 1997; 40: 1726-30.
85. Lavicka J, Sarissky M, Mirossay A, Sulla I, Mojzis J, Mirossay L. Diazepam enhances etoposide-induced cytotoxicity in U-87 MG human glioma cell line. Fundam Clin Pharmacol 2001; 15: 201-7.
86. Sarissky M, Lavicka J, Kocanová S, et al. Diazepam enhances hypericin-induced photocytotoxicity and apoptosis in human glioblastoma cells. Neoplasma 2005; 52: 352-9.
87. Musacchio T, Laquintana V, Latrofa A, Trapani G, Torchilin VP. PEG-PE micelles loaded with paclitaxel and surface modified by a PBR-ligand: synergistic anticancer effect. Mol Pharm 2009; 6: 468-79.
88. Miccoli L, Oudard S, Beurdeley-Thomas A, Dutrillaux B, Poupon MF. Effect of 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinoline carboxamide (PK11195), a specific ligand of the peripheral benzodiazepine receptor, on the lipid fluidity of mitochondria in human glioma cells. Biochem Pharmacol 1999; 58: 715-21.
89. Jendrossek V, Erdlenbruch B, Hunold A, Kugler W, Eibl H, Lakomek M. Erucylphosphocholine, a novel antineoplastic ether lipid, blocks growth and induces apoptosis in brain tumor cell lines in vitro. Int J Oncol 1999: 14: 15-22.
90. Jendrossek V, Kugler W, Erdlenbruch B, Eibl H, Lang F, Lakomek M. Erucylphosphocholine-induced apoptosis in chemoresistant glioblastoma cell lines: involvement of caspase activation and mitochondrial alterations. Anticancer Res 2001; 21: 3389-96.
91. Kugler W, Erdlenbruch B, Juenemann A, Heinemann D, Eibl H, Lakomek M. Erucylphosphocholine-induced apoptosis in glioma cells: involvement of death receptor signaling and caspase activation. J Neurochem 2002; 82: 1160-70.
92. Maaser K, Höpfner M, Jansen A, et al. Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human colorectal cancer cells. Br J Cancer 2001; 85: 1771-80.
93. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309-12.
94. Kugler W, Buchholz F, Köhler F, Eibl H, Lakomek M, Erdlenbruch B. Downregulation of Apaf-1 and caspase-3 by RNA interference in human glioma cells: Consequences for erucylphosphocholine-induced apoptosis. Apoptosis 2005; 10: 1163-74.
95. Bono F, Lamarche I, Prabonnaud V, Le Fur G, Herbert JM. Peripheral benzodiazepine receptor agonists exhibit potent antiapoptotic activities. Biochem Biophys Res Commun 1999; 265: 457-61.
96. Morris RL, Varnes ME, Kenney ME, et al. The peripheral benzodiazepine receptor in photodynamic therapy with the phthalocyanine photosensitizer Pc 4. Photochem Photobiol 2002; 75: 652-61.
97. Strohmeier R, Roller M, Sänger N, Knecht R, Kuhl H. Modulation of tamoxifen-induced apoptosis by peripheral benzodiazepine receptor ligands in breast cancer cells. Biochem Pharmacol 2002; 64: 99-107.
98. Marselli L, Trincavelli L, Santangelo C, et al. The role of peripheral benzodiazepine receptors on the function and survival of isolated human pancreatic islets. Eur J Endocrinol 2004; 151: 207-14.
99. Furre IE, Shahzidi S, Luksiene Z, et al. Targeting PBR by hexaminolevulinate-mediated photodynamic therapy induces apoptosis through translocation of apoptosis-inducing factor in human leukemia cells. Cancer Res 2005; 65: 11051-60.
100. Leducq-Alet N, Vin V, Savi P, Bono F. TNF-alpha induced PMN apoptosis in whole human blood: protective effect of SSR180575, a potent and selective peripheral benzodiazepine ligand. Biochem Biophys Res Commun 2010; 399: 475-9.
101. Boujrad N, Gaillard J-L, Garnier M, Papadopoulos V. Acute action of choriogonadotropin in Leydig tumor cells. Induction of a higher affinity benzodiazepine receptor related to steroid biosynthesis. Endocrinology 1994; 135: 1576-83.
102. Boujrad N, Vidic B, Papadopoulos V. Acute action of choriogonadotropin on Leydig tumor cells: Changes in the topography of the mitochondrial peripheral-type benzodiazepine receptor. Endocrinology 1996; 137: 5727-30.
103. Delavoie F, Li H, Hardwick M, et al. In vivo and in vitro peripheral-type benzodiazepine receptor polymerization: functional significance in drug ligand and cholesterol binding. Biochemistry 2003; 42: 4509-19.
104. Gonzalez-Polo RA, Carvalho G, Braun T, et al. PK 11195 potently sensitizes to apoptosis induction independently from the peripheral benzodiazepine receptor. Oncogene 2005; 24: 7503-13.
105. Zunino SJ, Storms DH. Resveratrol-induced apoptosis is enhanced in acute lymphoblastic leukemia cells by modulation of the mitochondrial permeability transition pore. Cancer Lett 2006; 240: 123-34.
106. Costa B, Salvetti A, Rossi L, et al. Peripheral benzodiazepine receptor: characterization in human T-lymphoma Jurkat cells. Mol Pharmacol 2006; 69: 37-44.
107. Ferlini C, Scambia G, Marone M, et al. Tamoxifen induces oxidative stress and apoptosis in oestrogen receptornegative human cancer cell lines. Br J Cancer 1999; 79: 257-63.
108. Gupta S, Ahmad N, Mukhtar H. Involvement of nitric oxide during phthalocyanine (Pc4) photodynamic therapy-mediated apoptosis. Cancer Res 1998; 58: 1785-8.
109. Crispo JA, Ansell DR, Piche M, et al. Protective effects of polyphenolic compounds on oxidative stress-induced cytotoxicity in PC12 cells. Can J Physiol Pharmacol 2010; 88: 429-38.
110. Choi J, Ifuku M, Noda M, Guilarte TR. Translocator protein (18 kDa)/peripheral benzodiazepine receptor specific ligands induce microglia functions consistent with an activated state. Glia 2011; 59: 219-30.
111. Sakai M, Ferraz-de-Paula V, Pinheiro ML, et al. Translocator protein (18 kDa) mediates the pro-growth effects of diazepam on Ehrlich tumor cells in vivo. Eur J Pharmacol 2010; 626: 131-8.
112. Dimitrova-Shumkovska J, Veenman L, Ristoski T, Leschiner S, Gavish M. Decreases in binding capacity of the mitochondrial 18 kda translocator protein accompany oxidative stress and pathological signs in rat liver after DMBA exposure. Toxicol Pathol 2010; 38: 957-68.
113. Dimitrova-Shumkovska J, Veenman L, Ristoski T, Leschiner S, Gavish M. Dimethylbenz[alpha]anthracene induces oxidative stress and reduces the binding capacity of the mitochondrial 18-kDa translocator protein in rat aorta. Drug Chem Toxicol 2010; 33: 337-47.
114. Dimitrova-Shumkovska J, Veenman L, Ristoski T, Leschiner S, Gavish M. Chronic high fat, high cholesterol supplementation decreases 18 kDa Translocator Protein binding capacity in association with increased oxidative stress in rat liver and aorta. Food Chem Toxicol 2010; 48: 910-21.
115. Nagler R, Savulescu D, Krayzler E, Leschiner S, Veenman L, Gavish M. Cigarette smoke decreases salivary 18 kDa translocator protein binding affinity-in association with oxidative stress. Curr Med Chem 2010; 17: 2539-46.
116. Xiao J, Liang D, Zhang H, Liu Y, Li F, Chen YH. 4'-Chlorodiazepam, a translocator protein (18 kDa) antagonist, improves cardiac functional recovery during postischemia reperfusion in rats. Exp Biol Med (Maywood) 2010; 235: 478-86.
117. Fares F, Bar-Ami S, Brandes JM, Gavish M. Gonadotropinand estrogen-induced increase of peripheral-type benzodiazepine binding sites in the hypophyseal-genital axis of rats. Eur J Pharmacol 1987; 133: 97-102.
118. Barnea ER, Fares F, Gavish M. Modulatory action of benzodiazepines on human term placental steroidogenesis in vitro. Mol Cell Endocrinol 1989; 64: 155-9.
119. Gavish M, Weizman R. Role of peripheral-type benzodiazepine receptors in steroidogenesis. Clin Neuropharmacol 1997; 20: 473-81.
120. Riad M, Mogos M, Thangathurai D, Lumb PD. Steroids. Curr Opin Crit Care 2002; 8: 281-4.
121. Gavish M, Okun F, Weizman A, Youdim MB. Modulation of peripheral benzodiazepine binding sites following chronic estradiol treatment. Eur J Pharmacol 1986; 127: 147-51.
122. Gavish M, Weizman A, Youdim MB, Okun F. Regulation of central and peripheral benzodiazepine receptors in progesterone-treated rats. Brain Res 1987; 409: 386-90.
123. Fares F, Bar-Ami S, Haj-Yehia Y, Gavish M. Hormonal regulation of peripheral benzodiazepine binding sites in female rat adrenal gland and kidney. J Recept Res 1989; 9: 143-57.
124. Amiri Z, Weizman R, Katz Y, et al. Testosterone and cyproterone acetate modulate peripheral but not central benzodiazepine receptors in rats. Brain Res 1991; 553: 155-8.
125. Weizman A, Amiri Z, Katz Y, Snyder SH, Gavish M. Testosterone prevents castration-induced reduction in peripheral benzodiazepine receptors in Cowper's gland and adrenal. Brain Res 1992; 572: 72-5.
126. Bar-Ami S, Amiri Z, Fares F, Gavish M. Modulation of peripheral benzodiazepine receptors in female rat genital organs by various gonadal steroids. Life Sci 1994; 54: 1965-75.
127. Bar-Ami S, Bendel N, Leschiner S, Levin E, Veenman L, Gavish M. The effects of prostaglandin F2alpha treatment on peripheral-type benzodiazepine receptors in the ovary and uterus during pseudopregnancy of rats. Biochem Pharmacol 2006; 71: 472-8.
128. Mazurika C, Veenman L, Weizman R, et al. Estradiol modulates uterine 18 kDa translocator protein gene expression in uterus and kidney of rats. Mol Cell Endocrinol 2009; 307: 43-9.
129. Bitran D, Carlson D, Leschiner S, Gavish M. Ovarian steroids and stress produce changes in peripheral benzodiazepine receptor density. Eur J Pharmacol 1998; 361: 235-42.
130. Sato T, Fukazawa Y, Kojima H, Enari M, Iguchi T, Ohta Y. Apoptotic cell death during the estrous cycle in the rat uterus and vagina. Anat Rec 1997; 248: 76-83.
131. Anholt RR, De Souza EB, Kuhar MJ, Snyder SH. Depletion of peripheral-type benzodiazepine receptors after hypophysectomy in rat adrenal gland and testis. Eur J Pharmacol 1985; 110: 41-6.
132. Tindall DJ, Chang CH, Lobl TJ, Cunningham GR. Androgen antagonists in androgen target tissues. Pharmacol Ther 1984; 24: 367-400.
133. Weizman R, Dagan E, Snyder SH, Gavish M. Impact of pregnancy and lactation on GABA(A) receptor and centraltype and peripheral-type benzodiazepine receptors. Brain Res 1997; 752: 307-14.
134. Avital A, Richter-Levin G, Leschiner S, et al. Acute and repeated swim stress effects on peripheral benzodiazepine receptors in the rat hippocampus, adrenal, and kidney. Neuropsychopharmacology 2001; 25: 669-78.
135. London SE, Clayton DF. Genomic and neural analysis of the estradiol-synthetic pathway in the zebra finch. BMC Neurosci 2010; 11: 46.
136. Golani I, Weizman A, Leschiner S, et al. Hormonal regulation of peripheral benzodiazepine receptor binding properties is mediated by subunit interaction. Biochemistry 2001; 40: 10213-22.
137. Batarseh A, Li J, Papadopoulos V. Protein kinase C epsilon regulation of translocator protein (18 kDa) Tspo gene expression is mediated through a MAPK pathway targeting STAT3 and c-Jun transcription factors. Biochemistry 2010; 49: 4766-78.
138. Bar-Ami S, Fares F, Gavish M. Altered peripheral benzodiazepine receptor density in human granulosa-lutein cells in relation to follicular maturity. Mol Cell Endocrinol 1991; 82: 285-91.
139. O'Hara MF, Charlap JH, Craig RC, Knudsen TB. Mitochondrial transduction of ocular teratogenesis during methylmercury exposure. Teratology 2002; 65: 131-44.
140. O'Hara MF, Nibbio BJ, Craig RC, Nemeth KR, Charlap JH, Knudsen TB. Mitochondrial benzodiazepine receptors regulate oxygen homeostasis in the early mouse embryo. Reprod Toxicol 2003; 17: 365-75.
141. Charlap JH, Donahue RJ, Knudsen TB. Exposure-disease continuum for 2-chloro-2'-deoxyadenosine, a prototype ocular teratogen. 3. Intervention with PK 11195. Birth Defects Res A Clin Mol Teratol 2003; 67: 108-15.
142. Villablanca AC, Jayachandran M, Banka C. Atherosclerosis and sex hormones: current concepts. Clin Sci (Lond) 2010; 119: 493-513.
143. Youssef DT, Ibrahim AK, Khalifa SI, Mesbah MK, Mayer AM, van Soest RW. New anti-inflammatory sterols from the Red Sea sponges Scalarispongia aqabaensis and Callyspongia siphonella. Nat Prod Commun 2010; 5: 27-31.
144. Bribes E, Bourrie B, Casellas P. Ligands of the peripheral benzodiazepine receptor have therapeutic effects in pneumopathies in vivo. Immunol Lett 2003; 88: 241-7.
145. Bribes E, Galiegue S, Bourrie B, Casellas P. Involvement of the peripheral benzodiazepine receptor in the development of cutaneous pathology in Mrl/Lpr mice. Immunol Lett 2003; 85: 13-8.
146. Lazzarini R, Malucelli BE, Palermo-Neto J. Reduction of acute inflammation in rats by diazepam: role of peripheral benzodiazepine receptors and corticosterone. Immunopharmacol Immunotoxicol 2001; 23: 253-65.
147. Lazzarini R, Sakai M, Costa-Pinto FA, Palermo-Neto J. Diazepam decreases leukocyte-endothelium interactions in situ. Immunopharmacol Immunotoxicol 2010; 32: 402-9.
148. Schlichter R, Keller AF, De Roo M, Breton JD, Inquimbert P, Poisbeau P. Fast nongenomic effects of steroids on synaptic transmission and role of endogenous neurosteroids in spinal pain pathways. J Mol Neurosci 2006; 28: 33-51.
149. Gottfried-Blackmore A, Sierra A, Jellinck PH, McEwen BS, Bulloch K. Brain microglia express steroid-converting enzymes in the mouse. J Steroid Biochem Mol Biol 2008; 109: 96-107.
150. Hauet T, Han Z, Wang Y, et al. Modulation of peripheral-type benzodiazepine receptor levels in a reperfusion injury pig kidney-graft model. Transplantation 2002; 74: 1507-15.
151. Favreau F, Rossard L, Zhang K, et al. Expression and modulation of translocator protein and its partners by hypoxia reoxygenation or ischemia and reperfusion in porcine renal models. Am J Physiol Renal Physiol 2009; 297: F177-90.
152. Batarseh A, Papadopoulos V. Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states. Mol Cell Endocrinol 2010; 327: 1-12.
153. Basile AS, Ostrowski NL, Skolnick P. Aldosterone-reversible decrease in the density of renal peripheral benzodiazepine receptors in the rat after adrenalectomy. J Pharmacol Exp Ther 1987; 240: 1006-13.
154. Ball JA, Ghatei MA, Sekiya K, Krausz T, Bloom SR. Diazepam binding inhibitor-like immunoreactivity (51-70): distribution in human brain, spinal cord and peripheral tissues. Brain Res 1989; 479: 300-5.
155. Anholt RR, De Souza EB, Oster-Granite ML, Snyder SH. Peripheral-type benzodiazepine receptors: autoradiographic localization in whole-body sections of neonatal rats. J Pharmacol Exp Ther 1985; 233: 517-26.
156. Gehlert DR, Yamamura HI, Wamsley JK. Autoradiographic localization of peripheral-type benzodiazepine binding sites in the rat brain, heart and kidney. Naunyn Schmiedebergs Arch Pharmacol 1985; 328: 454-60.
157. Marunaka Y. Hormonal and osmotic regulation of NaCl transport in renal distal nephron epithelium. Jpn J Physiol 1997; 47: 499-511.
158. Bribes E, Casellas P, Vidal H, Dussossoy D, Casellas D. Peripheral benzodiazepine receptor mapping in rat kidney. Effects of angiotensin II-induced hypertension. J Am Soc Nephrol 2002; 13: 1-9.
159. Veenman L, Gavish M. Peripheral-Type Benzodiazepine Receptors: Their implication in brain disease. Drug Dev Res 2000: 50: 355-70.
160. Norenberg MD, Rao KV, Jayakumar AR. Mechanisms of ammonia-induced astrocyte swelling. Metab Brain Dis 2005; 20: 303-18.
161. Ahboucha S. Neurosteroids and hepatic encephalopathy: an update on possible pathophysiologic mechanisms. Curr Mol Pharmacol 2011; 4: 1-13.
162. Schumacher M, Guennoun R, Stein DG, De Nicola AF. Progesterone: therapeutic opportunities for neuroprotection and myelin repair. Pharmacol Ther 2007; 116: 77-106.
163. Yi KD, Perez E, Yang S, Liu R, Covey DF, Simpkins JW. The assessment of non-feminizing estrogens for use in neuroprotection. Brain Res 2011; 1379: 61-70.
164. Meffre D, Pianos A, Liere P, et al. Steroid profiling in brain and plasma of male and pseudopregnant female rats after traumatic brain injury: analysis by gas chromatography/mass spectrometry. Endocrinology 2007; 148: 2505-17.
165. Ong WY, Kim JH, He X, Chen P, Farooqui AA, Jenner AM. Changes in brain cholesterol metabolome after excitotoxicity. Mol Neurobiol 2010; 41: 299-313.
166. Cutler SM, Pettus EH, Hoffman SW, Stein DG. Tapered progesterone withdrawal enhances behavioral and molecular recovery after traumatic brain injury. Exp Neurol 2005; 195: 423-9.
167. Yawno T, Yan EB, Walker DW, Hirst JJ. Inhibition of neurosteroid synthesis increases asphyxia-induced brain injury in the late gestation fetal sheep. Neuroscience 2007; 146: 1726-33.
168. Guilarte TR, Kuhlmann AC, O'Callaghan JP, Miceli RC. Enhanced expression of peripheral benzodiazepine receptors in trimethyltin-exposed rat brain: a biomarker of neurotoxicity. Neurotoxicology 1995; 16: 441-50.
169. Veenman L, Leschiner S, Spanier I, Weisinger G, Weizman A, Gavish M. PK 11195 attenuates kainic acid-induced seizures and alterations in peripheral-type benzodiazepine receptor (PBR) protein components in the rat brain. J Neurochem 2002; 80: 917-27.
170. Zheng W, Watts LT, Holstein DM, et al. Purinergic receptor stimulation reduces cytotoxic edema and brain infarcts in mouse induced by photothrombosis by energizing glial mitochondria. PLoS One 2010; 5: e14401.
171. Ziu M, Fletcher L, Rana S, Jimenez DF, Digicaylioglu M. Temporal differences in microRNA expression patterns in astrocytes and neurons after ischemic injury. PLoS One 2011; 6: e14724.
172. Veiga S, Carrero P, Pernia O, Azcoitia I, Garcia-Segura LM. Translocator protein 18 kDa is involved in the regulation of reactive gliosis. Glia 2007; 55: 1426-36.
173. Arlicot N, Katsifis A, Garreau L, et al. Evaluation of CLINDE as potent translocator protein (18 kDa) SPECT radiotracer reflecting the degree of neuroinflammation in a rat model of microglial activation. Eur J Nucl Med Mol Imaging 2008; 35: 2203-11. Erratum in: Eur J Nucl Med Mol Imaging 2008; 35: 2341. Kousignian, Isabelle [added].
174. Azcoitia I, Sierra A, Veiga S, Honda S, Harada N, Garcia-Segura LM. Brain aromatase is neuroprotective. J Neurobiol 47; 2001: 318-29.
175. Sierra A, Lavaque E, Perez-Martin M, Azcoitia I, Hales DB, Garcia-Segura LM. Steroidogenic acute regulatory protein in the rat brain: cellular distribution, developmental regulation and overexpression after injury. Eur J Neurosci 2003; 8: 1458-67.
176. Williams TA, Monticone S, Morello F, et al. Teratocarcinomaderived growth factor-1 is upregulated in aldosteroneproducing adenomas and increases aldosterone secretion and inhibits apoptosis in vitro. Hypertension 2010; 55: 1468-75.
177. Nadzialek S, Kestemont P. 17alpha-ethinylestradiol induces an imbalance between apoptosis and cell proliferation to sex steroid disruption in a testis culture of gudgeon, Gobio gobio. Environ Toxicol Chem 2010; 29: 881-6.
178. Grupen CG, Armstrong DT. Relationship between cumulus cell apoptosis, progesterone production and porcine oocyte developmental competence: temporal effects of follicular fluid during IVM. Reprod Fertil Dev 2010; 22: 1100-9.
179. Lin P, Rui R. Effects of follicular size and FSH on granulosa cell apoptosis and atresia in porcine antral follicles Mol Reprod Dev 2010; 77: 670-8.
180. Baudet C, Chevalier G, Chassevent A, et al. 1,25-Dihydroxyvitamin D3 induces programmed cell death in a rat glioma cell line. J Neurosci Res 1996; 4: 540-50.
181. Elias J, Marian B, Edling C, et al. Induction of apoptosis by vitamin D metabolites and analogs in a glioma cell line. Recent Results Cancer Res 2003; 164: 319-32.
182. Ansquer Y, Legrand A, Bringuier AF, et al. Progesterone induces BRCA1 mRNA decrease, cell cycle alterations and apoptosis in the MCF7 breast cancer cell line. Anticancer Res 2005; 25: 243-248.
183. Syed, V, Mukherjee K, Lyons-Weiler J, et al. Identification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profiling. Oncogene 2005; 24: 1774-87.
184. Cascio C, Guarneri R, Russo D, De Leo G, Guarneri M, Piccoli F, Guarneri P. A caspase-3-dependent pathway is predominantly activated by the excitotoxin pregnenolone sulfate and requires early and late cytochrome c release and cell-specific caspase-2 activation in the retinal cell death. J Neurochem 2002; 83: 1358-71.